United States
Germany
Japan
United Kingdom
China
PIK3R5 mouse monoclonal antibody, clone OTI4G9 (formerly 4G9)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
Products
PIK3R5 mouse monoclonal antibody, clone OTI2C6 (formerly 2C6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
PIK3R5 mouse monoclonal antibody, clone OTI5B1 (formerly 5B1)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
PIK3R5 mouse monoclonal antibody, clone OTI2A6 (formerly 2A6)
| Applications | IF, IHC, WB |
| Reactivities | Human, Dog, Rat, Monkey, Mouse |
PIK3R5 mouse monoclonal antibody, clone OTI2E4 (formerly 2E4)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PIK3R5 mouse monoclonal antibody, clone OTI6C5 (formerly 6C5)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PIK3R5 mouse monoclonal antibody, clone OTI4B11 (formerly 4B11)
| Applications | IF, IHC, WB |
| Reactivities | Human, Mouse, Rat |
PIK3R5 mouse monoclonal antibody, clone OTI2A3 (formerly 2A3)
| Applications | IF, WB |
| Reactivities | Human, Mouse, Rat |
活动过滤器
优化搜索结果
Category
Reactivities
Antibody Hosts
Isotypes
Clonalities
Brands
Families
Pathways
- Acute myeloid leukemia (29)
- Apoptosis (29)
- B cell receptor signaling pathway (29)
- Chemokine signaling pathway (29)
- Chronic myeloid leukemia (29)
- Colorectal cancer (29)
- Endometrial cancer (29)
- ErbB signaling pathway (29)
- Fc epsilon RI signaling pathway (29)
- Fc gamma R-mediated phagocytosis (29)
- Focal adhesion (29)
- Glioma (29)
- Insulin signaling pathway (29)
- Jak-STAT signaling pathway (29)
- Leukocyte transendothelial migration (29)
- Melanoma (29)
- Natural killer cell mediated cytotoxicity (29)
- Neurotrophin signaling pathway (29)
- Non-small cell lung cancer (29)
- Pancreatic cancer (29)
- Pathways in cancer (29)
- Phosphatidylinositol signaling system (29)
- Progesterone-mediated oocyte maturation (29)
- Prostate cancer (29)
- Regulation of actin cytoskeleton (29)
- Renal cell carcinoma (29)
- Small cell lung cancer (29)
- T cell receptor signaling pathway (29)
- Toll-like receptor signaling pathway (29)
- Type II diabetes mellitus (29)
- VEGF signaling pathway (29)
- mTOR signaling pathway (29)
